Fresh analysis indicates that people who come off new slimming jabs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who end conventional diet and exercise regimens.
Published data in a leading health publication demonstrates that while obese individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users using these medications must be cognizant of the risk of fast weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to starting mass within about one and a half years.
Weighing Approaches
The research, which examined 37 of trials involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with other pills.
Researchers emphasize that individuals who lose weight through lifestyle changes alone usually see a slower weight regain—perhaps 0.1 kg a month—after stopping.
Explaining the Fast Rebound
Nutrition scientists suggest the way of the drugs is key to understanding the accelerated weight return.
GLP-1 drugs mimic a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the system to produce less of its endogenous hormone, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication leads to appetite is no longer kept in check, making excessive eating much more probable."
An Ongoing Disease?
Medical guidelines advise the injections for people with weight-linked health risks, alongside recommended lifestyle changes.
A number of clinicians say that, due to the significant potential of weight regain, the therapy might need to be life-long.
This opinion is supported by drug manufacturers, who state that the findings "highlight the chronic nature of obesity," akin to managing diseases like hypertension.
User Testimonies
Users who have come off the medication report a powerful resurgence of hunger.
"I experienced a switch that goes on and I was suddenly extremely hungry," recalled a patient.
This challenge is exacerbated if users have not established sustainable lifestyle or habit changes during treatment.
Widespread Use
Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Adoption is more common among females compared to men.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are effective tools for weight loss, they are not a permanent cure and maintained weight loss likely depends on combined behavioural management.
